Usefulness of anti -CCP antibodies in rheumatic diseases in Indian patients [PDF]
The usefulness of anti-cyclic citrullinated peptide antibodies (anti-CCP antibodies) to identify rheumatic arthritis (RA) from other rheumatic diseases presenting with joint pain is not well studied.We aimed to determine the sensitivity and specificity of anti-CCP antibodies in Indian RA patients with respect to non-RA rheumatic diseases and to study ...
Gupta, R. +5 more
openaire +2 more sources
Assessment of Auto-antibodies (RF, Anti-CCP, and Anti-RA33) in Rheumatoid Arthritis Patients: Comparative study [PDF]
Rheumatoid arthritis is a chronic systemic autoimmune disease which is typically present in adulthood, more common in women than men and affecting e0.5- 1% of the adulth population.Many auto-antibodies could be implicated in the pathogenesis of the ...
Aldahhan, Hawraa A Ali +3 more
core +1 more source
A Study of Correlation of Disease Severity with Antibody Titers in Rheumatoid Arthritis [PDF]
Introduction: Rheumatoid Arthritis (RA) is one of the most frequent autoimmune diseases in the world which affects about 1% of people. Anti-Cyclic Citrullinated Peptides (Anti-CCP) is shown to be more specific than rheumatoid factor in the diagnosis of ...
Praveen Singh Madan +4 more
doaj +1 more source
Anti CCP antibodies in tuberculosis
Anti-cyclic citrullinated peptide (anti-CCP) antibodies have been considered very specific for rheumatoid arthritis (RA). Some studies have shown that these antibodies can be positive in infectious diseases like TB, HIV, etc.Fifty patients of tuberculosis both pulmonary and extra-pulmonary were enrolled in the study from inpatient and outpatient ...
Vikram, Londhey, Meghav M, Shah
openaire +2 more sources
The association of anti-CCP antibodies with disease activity in rheumatoid arthritis [PDF]
Antibodies to citrullinated proteins have been described in patients with rheumatoid arthritis (RA) and these appear to be the most specific markers of the disease. Our objective was to determine the frequency of antibodies to cyclic citrullinated peptides (CCPs) in patients with RA and the association of anti-CCP antibodies with disease activity ...
Serdaroğlu, Münevver +4 more
openaire +2 more sources
Relation Between Anti-CCP Antibodies and Sharp Score in Rheumatoid Arthritis [PDF]
Rheumatoid arthritis (RA) is a chronic, inflammatory, systemic rheumatic disease, very complex, with many different forms, progressive course, with pronounced changes in the joints, still unknown etiology and poorly understood pathology. Assessing of structural change can be done with proposed scores which observe changes on wrist and wrist joints, as ...
Mekic, Mevludin +2 more
openaire +2 more sources
Anti-cyclic citrullinated peptide antibody titers decrease in rheumatoid arthritis patients treated with tocilizumab: A pilot study [PDF]
Objectives: To analyze the effects of tocilizumab on peripheral B-cell subpopulation and its ability to produce anti-cyclic citrullinated peptide (CCP) antibody in patients with rheumatoid arthritis (RA).
Toshiyuki Bohgaki (222986) +17 more
core +1 more source
Anti-citrullinated protein antibodies in the diagnosis of rheumatoid arthritis (RA): diagnostic performance of automated anti-CCP-2 and anti-CCP-3 antibodies assays [PDF]
This study compares the diagnostic performance of a second generation anti-cyclic citrullinated peptide antibody (CCP2) with a third generation anti-CCP antibodies assay (CCP3), as well as the combination of both tests. Serum samples of 127 patients were analyzed.
Vos, I. +7 more
openaire +4 more sources
Peptidylarginine deiminases (PADs) catalyze citrullination, a post-translational modification playing a pathogenic role in anti-citrullinated protein antibody (ACPA)-positive rheumatoid arthritis (RA).
Søren Jacobsen (63876) +8 more
core +1 more source
COVID-19 convalescent plasma (CCP) is currently under investigation for both treatment and post-exposure prophylaxis. The active component of CCP mediating improved outcome is commonly reported as specific antibodies, particularly neutralizing antibodies,
Daniele Focosi +6 more
doaj +1 more source

